The Quantellect read.As of Nov 19, 2026, 6 active firms cover InflaRx N.V: 5 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. The target range is very wide, $2.00 to $14.00 (about 7.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $7.83 sits 612% above the current $1.10. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.06 next quarter toward $-0.31 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 active firms
Buy
Strong Buy117%
Buy467%
Neutral117%
Sell00%
Strong Sell00%
Based on 6 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$7.83
+612.1% upside
Average target across 6 active firms as of Nov 19, 2026 vs $1.10 current
Highest Target$14.00
Average Target$7.83
Lowest Target$2.00
Detailed analyst forecasts for IFRX
Showing 1–6 of 6 named analysts shown · 6 active firms in the rating projection
As of Nov 19, 2026, 5 of 6 active firms rate IFRX a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
IFRX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.06
Range $-0.07 – $-0.04 · 2 analysts · -31% YoY
Next period, 2 analysts expect InflaRx N.V. to earn $-0.06 a share (range $-0.07 – $-0.04), versus $-0.08 a year earlier. Full-year consensus is $-0.21, growing to $-0.31 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 2 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering InflaRx N.V.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IFRX.
#1
Yatin Suneja
Guggenheim · Rank #84
Buy
$14.00+1172.7% to target
Overall win rate
50%
+ Follow
#2
Joseph Schwartz
Leerink Partners · Rank #242
Neutral
No targeton IFRX
Overall win rate
36%
+ Follow
#3
Joseph Stringer
Needham · Rank #256
Buy
$8.00+627.3% to target
Overall win rate
36%
+ Follow
#4
EW
Edward White
HC Wainwright & Co. · Rank #376
Buy
$8.00+627.3% to target
Overall win rate
31%
+ Follow
#5
Andreas Argyrides
Oppenheimer · Rank #380
Buy
$5.00+354.5% to target
Overall win rate
41%
+ Follow
IFRX stock forecast FAQ
What is IFRX's average 12-month price target?+
The 6 active firms with a live target average $7.83 for InflaRx N.V. over the next 12 months, ranging from a $14.00 high to a $2.00 low, as of Nov 19, 2026.
Is IFRX stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 6 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for IFRX?+
The Street-high target is $14.00 (Guggenheim), and the Street-low is $2.00 (Leerink Partners). The average of all 6 active-firm targets is $7.83.
How many active Wall Street firms cover IFRX?+
6 active firms have a recognized rating on InflaRx N.V. as of Nov 19, 2026, and 6 active firms carry a live 12-month price target.
Who is the most accurate analyst covering IFRX?+
Among analysts who currently cover IFRX, Yatin Suneja of Guggenheim has the strongest overall Quantellect track record (Rank #84). Their current call is Buy with a $14.00 target.
What is InflaRx N.V.'s projected EPS for next quarter?+
The consensus estimate is $-0.06 per share (range $-0.07 – $-0.04) across 2 analysts. Full-year EPS is projected at $-0.21, rising to $-0.31 the following year.
How much revenue is InflaRx N.V. expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading IFRX lately?+
As of Nov 19, 2026, 5 of 6 active firms rate IFRX a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IFRX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.